SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-082813
Filing Date
2022-07-26
Accepted
2022-07-26 16:47:52
Documents
14
Period of Report
2022-07-20
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2221829d1_8k.htm   iXBRL 8-K 28451
2 EXHIBIT 3.1 tm2221829d1_ex3-1.htm EX-3.1 13870
3 EXHIBIT 3.2 tm2221829d1_ex3-2.htm EX-3.2 31376
  Complete submission text file 0001104659-22-082813.txt   258599

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20220720.xsd EX-101.SCH 3024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20220720_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20220720_pre.xml EX-101.PRE 22589
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2221829d1_8k_htm.xml XML 3623
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 221107645
SIC: 2834 Pharmaceutical Preparations